ROYAL BANK OF CANADA - ANGION BIOMEDICA CORP ownership

ANGION BIOMEDICA CORP's ticker is ANGN and the CUSIP is 03476J107. A total of 48 filers reported holding ANGION BIOMEDICA CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ANGION BIOMEDICA CORP
ValueSharesWeighting
Q3 2022$0458
+181.0%
0.00%
Q2 2022$0
-100.0%
163
-87.8%
0.00%
Q1 2022$3,000
-80.0%
1,337
-75.3%
0.00%
Q4 2021$15,000
-42.3%
5,404
+101.0%
0.00%
Q3 2021$26,000
+420.0%
2,688
+577.1%
0.00%
Q2 2021$5,000
-50.0%
397
-29.6%
0.00%
Q1 2021$10,0005640.00%
Other shareholders
ANGION BIOMEDICA CORP shareholders Q3 2021
NameSharesValueWeighting ↓
CM Management, LLC 600,000$552,0000.62%
Nantahala Capital Management 1,066,012$981,0000.06%
BVF INC/IL 1,071,297$986,0000.04%
Birchview Capital, LP 54,392$50,0000.04%
Park West Asset Management LLC 370,724$341,0000.02%
Cannell Capital 40,181$37,0000.01%
Patriot Financial Group Insurance Agency, LLC 36,500$34,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,000$161,0000.00%
Valeo Financial Advisors, LLC 63,659$59,0000.00%
Ergoteles LLC 78,857$73,0000.00%
View complete list of ANGION BIOMEDICA CORP shareholders